cRGD-targeted gold-based nanoparticles overcome EGFR-TKI resistance of NSCLC <i>via</i> low-temperature photothermal therapy combined with sonodynamic therapy-Reference-Cited by-同舟云学术

cRGD-targeted gold-based nanoparticles overcome EGFR-TKI resistance of NSCLC via low-temperature photothermal therapy combined with sonodynamic therapy

Published:2023 Issue:5 Volume:11 Page:1677-1691
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Lv Wenhao¹²,Wu Hao¹²,Zhang Yao¹,Li Hui¹,Shu Hong¹,Su Chunhong¹^ORCID,Zhu Yangyang¹²,Wang Ting¹²,Nie Fang¹²^ORCID

Affiliation:

1. Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, 730000, China

2. Gansu Province Clinical Research Center for Ultrasonography, Lanzhou, 730000, China

Abstract

cRGD-targeted gold-based nanoparticles inhibit the TGF-β/PDLIM5/SMAD signaling pathway to overcome EGFR-TKI resistance in NSCLC via low-temperature photothermal therapy combined with sonodynamic therapy.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/BM/D2BM01825J

Reference59 articles.

1. Cancer statistics, 2022

2. Lung cancer: current therapies and new targeted treatments

3. Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study